GEL Institutional Ownership

GENESIS ENERGY LP

Latest close $15.08 as of Aug 7, 2026

GEL institutional ownership at a glance

Follow GENESIS ENERGY LP institutional ownership through recent Schedule 13G and 13D filings. Compare reported shares, ownership percentages, filing dates, and changes in beneficial ownership over time.

Latest filing: Invesco filed Schedule 13G amendment on May 9, 2025, reporting 18.8M shares and 15.40% beneficial ownership.

Browse recent ownership filings How Schedule 13G works Why a 13G is not a trade report

How to read Schedule 13 ownership changes

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.

Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.

Current ownership filings and reported ownership changes are available on free access. Investor and Pro add filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and alerts. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

This gauge summarizes recent agreement across tracked institutional activity.

Latest filing May 9, 2025

Public consensus preview Accumulation leaning 62/100 institutional research score

1 tracked institution Latest filing May 9, 2025

1 accumulating across 1 comparable institution.

Accumulating1

Unchanged0

Reducing0

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week range data is not available for this security yet.

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Mar 31, 2025

Invesco May 9, 2025 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists, portfolio tools, and the first live gauge on the default tracker. Investor or Pro reveals research gauges across tracker views and unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 4 filing(s) · 1 older require more history access

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
Invesco CIK0000914208	Mar 31, 2025 observed May 9, 2025 filed · 39d Schedule 13G amendment	Reported accumulation	18.8M +1.4M	15.40% +1.20 pts	$15.69	$14.77	$15.08
Invesco CIK0000914208	Dec 29, 2023 observed Feb 12, 2024 filed · 45d Schedule 13G amendment	Reported accumulation	17.4M +1.2M	14.20% +1.00 pts	$11.58	$11.28	$15.08
Invesco CIK0000914208	Dec 30, 2022 observed Feb 3, 2023 filed · 35d Schedule 13G amendment	Reported accumulation	16.2M +2.0M	13.20% +1.60 pts	$10.21	$11.23	$15.08

Explore more institutional activity

Related research

Compare GEL with other securities showing similar institutional activity or recent accumulation across several tracked institutions.

Similar institutional activity

CRNX Crinetics Pharmaceuticals, Inc. 62/100 Accumulation leaning CASH PATHWARD FINANCIAL, INC. 62/100 Accumulation leaning OGS ONE Gas, Inc. 62/100 Accumulation leaning OVV Ovintiv Inc. 62/100 Accumulation leaning

Recent multi-institution accumulation

OCGN OCUGEN INC 2 accumulating Aug 7, 2026 DNTH Dianthus Therapeutics, Inc. /DE/ 2 accumulating Aug 7, 2026 SRPT Sarepta Therapeutics, Inc. 2 accumulating Aug 7, 2026 RARE ULTRAGENYX PHARMACEUTICAL IN 2 accumulating Aug 7, 2026